Symposium Day 1
Saturday, October 12th, 2024
PLENARY LECTURE
Moderator : dr. Ilham Uddin, SpJP(K), FIHA, FAsCC, FSCAI
08.30 – 08.50
Topic : Rheumatic heart disease prevention: past, current and future direction
Speaker : dr. Ade Meidian Ambari, SpJP(K), PhD, FIHA, FAsCC
09.10 – 09.20
Opening Ceremony
09.10 – 09.30
COFFEE BREAK
SYMPOSIUM I A
Current Clinical Management of Heart Failure and Upcoming Emerging Therapies
Moderator : dr. Mohamad Fauziar Ahnaf Murtazam, SpJP, FIHA, FAPSC
09.30 – 09.50
Topic 1
Benefits of SGLT2 Inhibitors in Heart Failure with Preserved Ejection Fraction
Speaker : dr. Yan Herry, SpJP(K), FIHA, FAsCC, FSCAI
09.50 – 10.10
Topic 2
Clinical Challenges in Diagnosis and Management Advanced Heart Failure: Tools and Strategies
Speaker : dr. Rarsari Soerarso, SpJP(K), FIHA
10.10 – 10.20
Open Discussion Symposium I A
SYMPOSIUM I B
Angintriz (Angina Pectoris Stabil-CCS) Advance care in stable angina pectoris; beyond conventional management.
Moderator : dr. Johan Gunadi, SpJP(K), FIHA
09.30 – 10.20
Topic 1
Role of Non invasive imaging in Chronic Coronary Syndrome
Speaker : dr. Dhira Amalin Tantina Alita Wardana, SpJP(K), FIHA
09.50 – 10.10
Topic 2
Optimization of effective energy metabolism as an anti anginal drugs in Chronic coronary syndrome
Speaker : dr. Susi Herminingsih, SpJP(K), FIHA, FAsCC
10.10 – 10.20
Open Discussion Symposium I B
SYMPOSIUM II A
The Future of Heart Failure Therapy: Optimizing Treatment Protocols for all spectrum of Heart Failure reduced Ejection Fraction.
Moderator : dr. Bambang Pamungkas, SpJP, FIHA
10.20 – 10.40
Topic 1
Guideline directed for Theraupeutic optimization Frontiers in HFrEF : the improtance of 4 pillars HF Guideline.
Speaker : dr. Adhitia Budy Prakoso, SpJP(K), FIHA
10.40 – 11.00
Topic 2
Synergy of GDMT and Execise in HFrEF to improve QoL
Speaker : dr. RR. Hari Hendriarti Satoto, SpJP(K), FIHA, FAPSC, AIFO-K, CRFC
11.00 – 11.10
Open Discussion Symposium II A
SYMPOSIUM II B
A Leap Forward of Anticoagulation Science in NSTEACS
Moderator : dr. Reza Satria Pratama, SpJP(K)
10.20 – 10.40
Topic 1
Dealing with NSTE ACS: invasive versus conservative management?
Speaker : dr. Ilham Uddin, SpJP(K), FIHA, FAsCC, FSCAI
10.40 – 11.00
Topic 2
Anticoagulation strategy in patient undergoing invasive management
Speaker : dr. Mohammad Yusuf Suseno, SpJP(K), FIHA
11.00 – 11.10
Open Discussion Symposium II B
SYMPOSIUM MAKAN SIANG
A Breakthrough treatment in LDL-C control among ASCVD patients
Moderator : dr. Ilham Uddin, SpJP(K), FIHA, FAsCC, FSCAI
11.25 – 11.45 Topic 1
Current insight on LDL-C control & treatment among ASCVD patients in Indonesia.
Speaker : dr. Sodiqur Rifqi, SpJP(K), FIHA, FAsCC, FSCAI
11.45 – 12.05
Topic 2
Deep dive on PCSK9 inhibitors Pharmacology on LDL-C lowering & CV Outcome trials
Speaker : Dr. dr. Anwar Santoso, Sp.JP(K), FIHA, FASCC
12.05 – 12.25
Topic 3
Evolocumab for Early Reduction of LDL-cholesterol Level in Patients with Acute Coronary Syndrome (ACS).
Speaker : dr. Bahrudin, MSi.Med, PhD, SpJP(K), FIHA
12.25 – 12.40
Open Discussion Symposium Makan Siang
SYMPOSIUM III A
Innovative approaches in management of chronic coronary syndrome.
Moderator :
dr. Bahrudin, MSi.Med, PhD, SpJP(K), FIHA
13.10 – 13.30
Topic 1
Next Steps in Lipid Therapy: Integrating Non-Statin Agents for Optimal Results.
Speaker : dr. Sodiqur Rifqi, SpJP(K), FIHA, FAsCC, FSCAI
13.30 – 13.50
Topic 2
Precision medicine in chronic coronary syndrome; genetic guided therapy.
Speaker: dr. Nani Maharani, M.Si.Med., Ph.D.
13.50 – 14.00
Open Discussion Symposium III A
SYMPOSIUM III B
Shaping the Future of Cardiovascular Pharmacotherapy: Unleashing the Potential of Platelet Control
Moderator : dr. Safir, SpJP(K), FIHA, FAPSC
13.10 – 13.30
Topic 1
Balancing effcacy and bleeding risk on anti thrombotic therapy in ACS patient.
Speaker: dr. Yan Herry, SpJP(K), FIHA, FAsCC, FSCAI
13.30 – 13.50
Topic 2
Implementation use of potent antiplatelet for ACS in Indonesia: National Guideline Recommendation.
Speaker: Dr. dr. Dafsah Arifa Juzar, Sp.JP (K) FIHA, FAsCC, FESC, FAPSIC, FSCAI
13.50 – 14.00 Open Discussion Symposium III B
SYMPOSIUM IV A
The Ultimate Heart Protectors: Beta-Blockers in the Battle Against Cardiovascular Disease
Moderator : dr. Mustika Mahbubi, SpJP, FIHA
14.00 – 14.20
Topic 1
Defining the risk of sudden cardiac death in sport participation for patient with ventricular arrhythmia.
Speaker : dr. Pipin Ardhianto, SpJP(K), FIHA
14.20 – 14.40
Topic 2
Achieving maximal tolerated dose of betablocker for CVD prevention.
Speaker : dr. M. Fauziar Ahnaf M, SpJP, FIHA, FAPSC
14.40 – 14.50
Open Discussion Symposium IV A
SYMPOSIUM IV B
PT. NOVO Integrating diabetes and cardiovascular therapy for improving otucomes.
Moderator : dr. Aruman Yudanto Aribowo Binarso Mochtar, SpJP(K), FIHA, FAPSC
14.00 – 14.20
Topic 1
Guideline directed medical treatment for Managing patient with ASCVD and Type 2 DM
Speaker : dr. Detrianae, SpJP(K)
14.20 – 14.40
Topic 2
Novel Treatment Choice for People with Type 2 Diabetes
Speaker : Dr. dr. K. Heri Nugroho HS., SpPD(K), KEM
14.40 – 14.50
Open Discussion Symposium IV B
SYMPOSIUM V A
Addressing interplay between hypertension and angina
Moderator : dr. Agus Probo Suyono, Sp.JP(K), FIHA
14.50 – 15.10
Topic 1
Chest Pain Evaluation Lege Artis: Ensuring Accuracy and Excellence in Clinical Practice
Speaker : dr. Alvin Tonang, Sp.JP(K), FIHA
15.10 – 15.30
Topic 2
Innovations in the Treatment of Hypertension: Emerging Therapies and Guidelines
Speaker : dr. Yan Herry, SpJP(K), FIHA, FAsCC, FSCAI
15.30 – 15.40
Open Discussion Symposium V A
SYMPOSIUM V B
Tackling the Toughest Clinical Challenges of Hypertension and Anticoagulant Therapy
Moderator : dr. Ignatius Faizal Yuwono, SpJP(K), FIHA
14.50 – 15.10
Topic 1
Combining Forces Against Hypertension: Innovative Drug Therapies and Strategies
Speaker : dr. Anggit Pudjiastuti, SpJP, FIH
15.10 – 15.30
Topic 2
Practical guide to common clinical challenges in patients with DOAC (bleed, perioperative, drug interactions)
Speaker : dr. Aruman Yudanto Aribowo Binarso Mochtar, SpJP(K), FIHA, FAPSC
15.30 – 15.40
Open Discussion Symposium V B
Symposium Day 2
Sunday, October 13th, 2024
SYMPOSIUM VI A
Emerging Strategies in Managing Cardiogenic Shock and Acute Heart Failure
Moderator : dr. Ferry Christian, SpJP(K)
08.30-08.50
Topic 1
Acute heart failure and cardiogenic shock therapy : role of PDE III inhibitor
Speaker : dr. Alvin Tonang, SpJP(K), FIHA
08.50 – 09.10
Topic 2
Emergency echocardiography: benefits, applications and best practices
Speaker : dr. Susi Herminingsih, SpJP(K), FIHA, FAsCC
09.10 – 09.20
Open Discussion Symposium VI A
SYMPOSIUM VI B
Innovative Horizons: Anticoagulant Choice for Stroke Prevention
Moderator : dr. Sefri Noventi Sofia, SpJP(K), MSi.Med, FIHA, FAsCC
08.30-08.50
Topic 1
The journey of anticoagulant for stroke prevention in AF: translating clinical trial to clinical practice
Speaker : dr. Pipin Ardhianto, Sp.JP(K), FIHA
08.50 – 09.10
Topic 2
A Review of Potential Mechanisms of Cryptogenic Stroke and a Recommended Approach to Diagnosis
Speaker : dr. Yovita Andhitara, Sp.S(K), MSi.Med, FINS, FINA
09.10 – 09.20
Open Discussion Symposium VI B
SYMPOSIUM VII A
Cardiovascular Risk Factors Management: A Comprehensive Update
Moderator : dr. Pipin Ardhianto, SpJP(K), FIHA
09.20 – 09.40
Topic 1
Hidden dangers: Unveiling the synergestics impact of dyslipidemia and hypertension in CVD
Speaker : dr. Safir, SpJP(K), FIHA, FAPSC
09.40 – 10.00
Topic 2
Artificial intelligence in risk factors prediciton models of CVD
Speaker : dr. RR. Hari Hendriarti Satoto, SpJP(K), FIHA, FAPSC, AIFO-K, CRFC
10.00-10.10
Open Discussion Symposium VII A
SYMPOSIUM VII B
Embracing Excellence in Lipid Control: Setting New Standards in Cardiovascular Therapy
Moderator : dr. Dedie Setiadi, SpJP, FIHA
09.20 – 09.40
Topic 1
Lipid Control in Cardiovascular Diseases: what we already know, what we should understood, and what is to come?
Speaker : dr. Mohammad Yusuf Suseno, SpJP(K), FIHA
09.40 – 10.00
Topic 2
Exploring the potential treatment in Rheumatic Heart Disease Management: Statin beyond lipid lowering.
Speaker : dr. Sulistiyati Bayu Utami, PhD, SpJP, FIHA
10.00 – 10.10
Open Discussion Symposium VI B
10.10 – 10.20
Coffee Break
SYMPOSIUM VIII A
Revolutionizing Cardiovascular Health: Unveiling the Power of Next-Generation Lipid Management
Moderator : dr. Agus Probo Suyono, SpJP(K), FIHA
10.20 – 10.40
Topic 1
Overcoming Barriers to LDL Reduction: Exploring Effective Alternatives in Lipid Therapy
Speaker : dr. Sulistiyati Bayu Utami, PhD, SpJP, FIHA
10.40 – 11.00
Topic 2
The Impact of non pharmacological treatment on CV Outcomes: focous on nutrition.
Speaker : Dr. dr. Niken Puruhita, M.MedSc., Sp.GK(K).
11.00- 11.10
Case Discussion
SYMPOSIUM VIII B
Anticoagulant : From Preventive Measures to Therapeutic Triumphs
Moderator : dr. Sudiyoko, SpJP, FIHA
10.20 – 10.40
Topic 1
Atrial Fibrillation in Chronic Kidney Disease : An overview of Oral Anticoagulant
Speaker : dr. Aruman Yudanto Aribowo Binarso Mochtar, SpJP(K), FIHA, FAPSC
10.40 – 11.00
Topic 2
Which Oral Anticoagulant Therapy is preffered in Venous Thromboembolism with Cancer ?
Speaker : dr. Novi Anggriyani, SpJP(K), FIHA, FICA
11.00- 11.10
Case Discussion
Symposium Makan Siang
Transcatheter intervention in Acyanotic Congenital Heart Disease
Moderator : dr. Susi Herminingsih, SpJP(K), FIHA, FAsCC
11.25- 11.45
Topic 1
Role of Echocardiography in transcatheter defect closure
Speaker : dr. Rille Puspitoadhi Harjoko, SpJP, FIHA
11.45 – 12.05
Topic 2
Transcatheter ASD closure: challenge in pediatric and adult popoulation.
Speaker : dr. Sefri Noventi Sofia, Sp.JP (K), MSi.Med, FIHA, FAsCC
12.05 – 12.25
Topic 3
Transcatheter VSD device closure, what strategy should we took.
Speaker : dr. Radityo Prakoso, Sp.JP(K), FIHA, FAPSIC, FAsCC, FESC, FACC, FSCAI
12.25 – 12.40
Case Discussion
SYMPOSIUM IX
Tough Decision in Cardiology: Revascularization in Dilated Ischemic Cardiomyopathy, Pros & Cons
Moderator : dr. Ilham Uddin, SpJP(K), FIHA, FAsCC, FSCAI
13.10 – 13.30
Topic 1
Revascularization on Dilated Ischemic Cardiomyopathy : Pros
Speaker : dr. Mohamad Fauziar Ahnaf Murtazam, SpJP, FIHA, FAPSC
13.30 – 13.5
Topic 2
Revascularization on Dilated Ischemic Cardiomyopathy : Cons
Speaker : dr. Safir, SpJP(K), FIHA, FAPSC
13.50 – 14.00
Case Discussion
